Aspirin gegen das Altern? : für wen und wieviel?

Oelz, O. and Meier, P. J.. (1990) Aspirin gegen das Altern? : für wen und wieviel? Therapeutische Umschau, Bd. 47, H. 8. pp. 648-652.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A5261774

Downloads: Statistics Overview


Aspirin has been successfully used in the secondary prophylaxis of myocardial infarction, cerebral vascular events and peripheral arterial disease. Regular aspirin intake may further be beneficial in asymptomatic healthy male with cardiovascular risk factors over the age of 50. There is no good evidence that aspirin prevents the development of atherosclerosis and thromboembolic events in healthy individuals.
Faculties and Departments:11 Rektorat und Verwaltung > Vizerektorat Forschung
UniBasel Contributors:Meier-Abt, Peter J.
Item Type:Article, refereed
Article Subtype:Book Review
Publisher:Hans Huber
Note:Variant title: >>L'<<aspirine contre le vieillissement? : pour qui et à quelle chose? -- Variant title: Aspirin against growing old? : for whom and how much? -- Note: Standartisierter englischer Titel: Aspirin against aging? for whom and how much? -- Publication type according to Uni Basel Research Database: Journal item
Related URLs:
Identification Number:
Last Modified:22 Mar 2012 14:23
Deposited On:22 Mar 2012 13:36

Repository Staff Only: item control page